Skip to content

Legal status · United Kingdom

Is Rapamycin plus acarbose legal in the United Kingdom?

Written by Reviewed Sep 2026

Prescription routeLongevityNo studies in people cited

Direct answer

Rapamycin plus acarbose is available in the United Kingdom only through a prescriber. Its legal category is "Prescription only, each drug separately; no licensed combination". It is not sold over the counter. Using it rests on the prescriber's judgment, not on an approval to sell it. Vials sold "for research use only" fall outside that route, and the label does not make them legal to use in people. On the evidence, no study in people is cited on its profile.

People given it
0
Found nothing
0

Legal category

Prescription only, each drug separately; no licensed combination

Each drug separately. Using them together is off-label.

Reviewed Sep 2026. This is a legal category, not legal advice.

A "research use only" label on a vial does not make it legal to use on people.

Rapamycin plus acarbose in the United Kingdom at a glance

Legal categoryPrescription only, each drug separately; no licensed combination
NoteEach drug separately. Using them together is off-label.
MHRA approval statusPrescription route only; no broad MHRA approval to sell it
Studies in people0 of 7 sources on the profile
ReviewedSep 2026

The legal category and note come from the Rapamycin plus acarbose profile. We checked them against Medicines and Healthcare products Regulatory Agency (MHRA) listings on the reviewed date.

What this means

  • 01

    Rapamycin plus acarbose reaches patients in the United Kingdom only through a prescriber. Usually that is for one narrow use on its label, or through a compounding pharmacy (a pharmacy that mixes its own version) with a prescription.

  • 02

    That route rests on the prescriber's judgment. For pharmacy-mixed products, it also rests on the pharmacy's own quality checks, not on an approval of the product for sale.

  • 03

    Buying it online "for research use only" is outside that route. The label does not make it legal to use in people.

What Rapamycin plus acarbose is

No person has taken these two together in any study. In mice started at 9 months, typical lifespan rose 28 percent in females and 34 to 37 percent in males. That is the biggest pooled gain the NIA mouse lifespan program has published, and it worked at all three labs in both sexes. In males it beat earlier rapamycin-only runs. In females it did not.

Rapamycin and acarbose are the two drugs with the most repeated lifespan wins in the NIA mouse lifespan program. In 2017 the program fed them together.

How it works: Rapamycin blocks mTORC1, a growth switch. Acarbose blocks gut enzymes that break down starch, so blood sugar rises less after a meal.

Approval history: Both drugs are FDA-approved for other uses (sirolimus for transplant rejection and other uses; acarbose for type 2 diabetes). The combination is not approved for anything and has never been given to people in a study. The lifespan result is in mice. It was compared with each drug alone from earlier studies, not tested side by side at the same time.

How MHRA treats this kind of product

Licenses medicines for sale in the UK. A compound without a licence to be sold (a marketing authorisation) is an unlicensed medicine. The law only lets it reach people through a prescriber, under the specials scheme (unlicensed medicines made for one patient's needs). It cannot be sold as a research product.

The legal category above is how The Longevity Archive reads Medicines and Healthcare products Regulatory Agency listings for Rapamycin plus acarbose on the reviewed date. It is not a legal opinion. Rules change. Bringing a compound into the country, prescribing it and owning it can each be treated differently. Check with the agency before you act on anything here.

Check MHRA directly

Rapamycin plus acarbose in sport and the military

Whether Rapamycin plus acarbose is banned in sport is set by the World Anti-Doping Code and by military rules, not by its legal status in the United Kingdom. Before you compete or get tested, look up Rapamycin plus acarbose by name on the Prohibited List, or look up a named product in Global DRO. Under the World Anti-Doping Code, category S0 bans, at all times, any drug-like substance that meets two tests. No other section of the List covers it. And no government health regulator anywhere has a current approval for it as a treatment in people. Many substances that are approved somewhere are banned by name in another section. So approval does not mean a substance is allowed in sport.

The rules you compete or serve under decide this, not this page.

Rapamycin plus acarbose in other countries

Frequently asked questions

Is Rapamycin plus acarbose legal in the United Kingdom?

Rapamycin plus acarbose is available in the United Kingdom only through a prescriber. Its legal category is "Prescription only, each drug separately; no licensed combination". It is not sold over the counter. Using it rests on the prescriber's judgment, not on an approval to sell it. Vials sold "for research use only" fall outside that route, and the label does not make them legal to use in people. On the evidence, no study in people is cited on its profile. Note: Each drug separately. Using them together is off-label.

Can I buy Rapamycin plus acarbose in the United Kingdom?

Only through a prescriber. In the United Kingdom, Rapamycin plus acarbose has the legal category "Prescription only, each drug separately; no licensed combination". You cannot buy it over the counter. Products sold online "for research use only" are not the same as a product a prescriber orders and a pharmacy hands out. Note: Each drug separately. Using them together is off-label.

Is Rapamycin plus acarbose MHRA approved?

No. In the United Kingdom, Rapamycin plus acarbose has the legal category "Prescription only, each drug separately; no licensed combination". That is not a MHRA approval to sell it. For comparison, its US FDA status is: Both drugs are FDA-approved for other uses (sirolimus for transplant rejection and other uses; acarbose for type 2 diabetes). The combination is not approved for anything and has never been given to people in a study. The lifespan result is in mice. It was compared with each drug alone from earlier studies, not tested side by side at the same time.. On the evidence, no study in people is cited on its profile.

Related compounds in the United Kingdom

Full research profile

How Rapamycin plus acarbose works, the studies we cite, FDA status and the full legal summary are all on its compound profile.

Rapamycin plus acarbose profile

This page is general information about the legal status of Rapamycin plus acarbose in the United Kingdom, current as of Sep 2026. It is not legal advice. Legal status changes. For your own situation, check with Medicines and Healthcare products Regulatory Agency or ask a lawyer. Educational use only. This database summarizes published research and is not medical advice. Where a dose appears it is a record of what a trial or clinic ran, or what people describe doing, with its source attached. Nothing here is a recommendation for personal use. Sellers named on the price pages are ranked by certificate tier, then price, and any affiliate income is disclosed there. Naming a seller is not a recommendation to buy or use anything.